[HTML][HTML] Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

S De Sanjosé, L Alemany, J Ordi, S Tous… - European journal of …, 2013 - Elsevier
Background Human papillomavirus (HPV) contribution in vulvar intraepithelial lesions (VIN)
and invasive vulvar cancer (IVC) is not clearly established. This study provides novel data …

Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva

MT Faber, FL Sand, V Albieri, B Norrild… - … journal of cancer, 2017 - Wiley Online Library
In this updated systematic review and meta‐analysis, we estimate the pooled prevalence of
human papillomavirus (HPV) DNA and HPV type distribution in squamous cell carcinoma of …

[HTML][HTML] Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women

M Preti, JC Rotondo, D Holzinger, L Micheletti… - Infectious Agents and …, 2020 - Springer
Background Vulvar squamous cell carcinoma (VSCC) is a rare malignancy of the female
genital tract. We aimed to determine the mucosal high-risk human papillomavirus (HPV) …

Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis

Z Li, P Liu, Z Wang, Z Zhang, Z Chen, R Chu… - The Lancet …, 2023 - thelancet.com
Summary Background Human papillomavirus (HPV) DNA and p16 INK4a positivity have
crucial roles in the pathogenesis of vulvar cancer and vulvar intraepithelial neoplasia. We …

Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction

JW Gargano, EJ Wilkinson, ER Unger… - Journal of lower …, 2012 - journals.lww.com
Objective The study aimed to determine the baseline prevalence of human papillomavirus
(HPV) types in invasive vulvar cancer (IVC) and vulvar intraepithelial neoplasia 3 (VIN 3) …

[HTML][HTML] Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions

B Serrano, S de Sanjosé, S Tous, B Quiros… - European journal of …, 2015 - Elsevier
Objective Human papillomavirus (HPV) vaccines can potentially control cervical cancer and
help to reduce other HPV-related cancers. We aimed to estimate the relative contribution …

The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned

HP van de Nieuwenhof, LCLT van Kempen… - … Biomarkers & Prevention, 2009 - AACR
Purpose: High-risk human papilloma virus (HPV) plays a role in the development of a subset
of vulvar squamous cell carcinomas. Uncertainty exists about the true impact of HPV in this …

[HTML][HTML] Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples

L Alemany, M Saunier, L Tinoco, B Quirós… - European journal of …, 2014 - Elsevier
Aim This work describes the human papillomavirus (HPV) prevalence and the HPV type
distribution in a large series of vaginal intraepithelial neoplasia (VAIN) grades 2/3 and …

p16 immunostaining allows for accurate subclassification of vulvar squamous cell carcinoma into HPV-associated and HPV-independent cases

AS Cheng, AN Karnezis, S Jordan… - International Journal …, 2016 - journals.lww.com
The aim of this study was to compare morphologic assessment and p16
immunohistochemistry (IHC) in the determination of human papilloma virus (HPV) status in …

Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors

JS Smith, DM Backes, BE Hoots, RJ Kurman… - Obstetrics & …, 2009 - journals.lww.com
OBJECTIVE: Data on human papillomavirus (HPV) prevalence in vulvar and vaginal
cancers are limited. These data are important to predict the potential future effect of …